🚀 Unlock the Future of CNS Drug Discovery with Pharmidex 🧠
August 28, 2024
At
Pharmidex, we're dedicated to advancing the frontier of Central Nervous System (CNS) drug discovery. With our deep expertise in
in vitro and
in vivo models, DMPK studies, and translational science, we provide end-to-end solutions that accelerate your CNS projects from concept to clinic.
🔬 Our CNS services include:
- In vitro assays for neurotoxicity, neuroprotection, and receptor binding.
- In vivo models for a wide range of CNS disorders including
neurodegeneration, psychiatric disorders, and pain. - DMPK studies with a focus on CNS penetration, blood-brain barrier
studies, and more. - Expert consultancy to optimize your CNS drug development strategy.
Partner with us to bring innovative therapies to patients faster. Let's collaborate and make breakthroughs in CNS research together!
🌐 Explore our CNS services:
https://www.pharmidex.com/CNS
#CNS #Neuroscience #DrugDiscovery #Pharmidex #LifeSciences #Neuropharmacology #DMPK #TranslationalResearch #Biotech #Pharma
We are pleased to share that Ian Knowles and Martin Barrett will attend Pharmacology 2025, organized by The British Pharmacological Society (BPS), at the ICC Belfast from 16–18 December 2025. They will host a Pharmidex exhibition stand, showcasing our key services and their importance in drug discovery and development. Ian and Martin will be delighted to meet attendees, exchange ideas, and explore new collaboration opportunities. Come and say hello!
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!
